Cargando…
Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout
BACKGROUND: Gout is a metabolic disease and is the most common form of inflammatory arthritis affecting men. However, the pathogenesis of gout is still uncertain, and novel biomarkers are needed for early prediction and diagnosis of gout. The aim of this study was to develop a systemic metabolic pro...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989453/ https://www.ncbi.nlm.nih.gov/pubmed/29871692 http://dx.doi.org/10.1186/s13075-018-1600-5 |
_version_ | 1783329467188379648 |
---|---|
author | Zhang, Yannan Zhang, Huanzhen Chang, Dong Guo, Fuchuan Pan, Hongzhi Yang, Yuexin |
author_facet | Zhang, Yannan Zhang, Huanzhen Chang, Dong Guo, Fuchuan Pan, Hongzhi Yang, Yuexin |
author_sort | Zhang, Yannan |
collection | PubMed |
description | BACKGROUND: Gout is a metabolic disease and is the most common form of inflammatory arthritis affecting men. However, the pathogenesis of gout is still uncertain, and novel biomarkers are needed for early prediction and diagnosis of gout. The aim of this study was to develop a systemic metabolic profile of patients with asymptomatic hyperuricemia (HUA) and gout by using a metabolomics approach, and find potential pathophysiological mechanisms of and markers of predisposition to gout. METHODS: Serum samples were collected from 149 subjects, including 50 patients with HUA, 49 patients with gout and 50 healthy controls. (1)H nuclear magnetic resonance (NMR) spectroscopy combined with principal components analysis and orthogonal partial least squares-discriminant analysis were used to distinguish between samples from patients and healthy controls. Clinical measurements and pathway analysis were also performed to contribute to understanding of the metabolic change. RESULTS: By serum metabolic profiling, 21 metabolites including lipids and amino acids were significantly altered in patients with HUA or gout. The levels of identified biomarkers together with clinical data showed apparent alteration trends in patients with HUA or gout compared to healthy individuals. According to pathway analysis, three and five metabolic pathways were remarkably perturbed in patients with HUA or gout, respectively. These enriched pathways involve in lipid metabolism, carbohydrate metabolism, amino acids metabolism and energy metabolism. CONCLUSIONS: Taken together, we identified the biomarker signature for HUA and gout, which provides biochemical insights into the metabolic alteration, and identified a continuous progressive axis of development from HUA to gout. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-018-1600-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5989453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59894532018-06-21 Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout Zhang, Yannan Zhang, Huanzhen Chang, Dong Guo, Fuchuan Pan, Hongzhi Yang, Yuexin Arthritis Res Ther Research Article BACKGROUND: Gout is a metabolic disease and is the most common form of inflammatory arthritis affecting men. However, the pathogenesis of gout is still uncertain, and novel biomarkers are needed for early prediction and diagnosis of gout. The aim of this study was to develop a systemic metabolic profile of patients with asymptomatic hyperuricemia (HUA) and gout by using a metabolomics approach, and find potential pathophysiological mechanisms of and markers of predisposition to gout. METHODS: Serum samples were collected from 149 subjects, including 50 patients with HUA, 49 patients with gout and 50 healthy controls. (1)H nuclear magnetic resonance (NMR) spectroscopy combined with principal components analysis and orthogonal partial least squares-discriminant analysis were used to distinguish between samples from patients and healthy controls. Clinical measurements and pathway analysis were also performed to contribute to understanding of the metabolic change. RESULTS: By serum metabolic profiling, 21 metabolites including lipids and amino acids were significantly altered in patients with HUA or gout. The levels of identified biomarkers together with clinical data showed apparent alteration trends in patients with HUA or gout compared to healthy individuals. According to pathway analysis, three and five metabolic pathways were remarkably perturbed in patients with HUA or gout, respectively. These enriched pathways involve in lipid metabolism, carbohydrate metabolism, amino acids metabolism and energy metabolism. CONCLUSIONS: Taken together, we identified the biomarker signature for HUA and gout, which provides biochemical insights into the metabolic alteration, and identified a continuous progressive axis of development from HUA to gout. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-018-1600-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-05 2018 /pmc/articles/PMC5989453/ /pubmed/29871692 http://dx.doi.org/10.1186/s13075-018-1600-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zhang, Yannan Zhang, Huanzhen Chang, Dong Guo, Fuchuan Pan, Hongzhi Yang, Yuexin Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
title | Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
title_full | Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
title_fullStr | Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
title_full_unstemmed | Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
title_short | Metabolomics approach by (1)H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
title_sort | metabolomics approach by (1)h nmr spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989453/ https://www.ncbi.nlm.nih.gov/pubmed/29871692 http://dx.doi.org/10.1186/s13075-018-1600-5 |
work_keys_str_mv | AT zhangyannan metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout AT zhanghuanzhen metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout AT changdong metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout AT guofuchuan metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout AT panhongzhi metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout AT yangyuexin metabolomicsapproachby1hnmrspectroscopyofserumrevealsprogressionaxesforasymptomatichyperuricemiaandgout |